Secor Capital Advisors’s Medifast MED Stock Holding History

Secor Capital Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,706	Closed	-$588K	–	507
2018 Q4	$588K	Buy	+4,706	New	+$805K	0.08%	294
2018 Q3	–	Sell	-32,278	Closed	-$5.17M	–	519
2018 Q2	$5.17M	Sell	32,278 -20,718	-39%	-$2.65M	0.44%	46
2018 Q1	$4.95M	Sell	52,996 -13,147	-20%	-$982K	0.41%	54
2017 Q4	$4.62M	Buy	66,143 +56,001	+552%	+$3.71M	0.18%	78
2017 Q3	$602K	Sell	10,142 -1,534	-13%	-$76.3K	0.06%	331
2017 Q2	$484K	Buy	+11,676	New	+$508K	0.04%	351
2017 Q1	–	Sell	-11,753	Closed	-$489K	–	540
2016 Q4	$489K	Sell	11,753 -14,075	-54%	-$567K	0.06%	357
2016 Q3	$976K	Sell	25,828 -13,340	-34%	-$478K	0.11%	260
2016 Q2	$1.3M	Buy	+39,168	New	+$1.26M	0.16%	203
2016 Q1	–	Sell	-11,915	Closed	-$362K	–	696
2015 Q4	$362K	Buy	+11,915	New	+$355K	0.1%	329
2015 Q2	–	Sell	-9,613	Closed	-$288K	–	500
2015 Q1	$288K	Buy	+9,613	New	+$305K	0.11%	320
2014 Q4	–	Sell	-12,220	Closed	-$401K	–	429
2014 Q3	$401K	Buy	+12,220	New	+$375K	0.23%	164

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Secor Capital Advisors's MED Position: Q1 2019 in Review

Secor Capital Advisors sold out of Medifast (MED) in Q1 2019, closing a stake of 4,706 shares — an estimated $588K sold.

Secor Capital Advisors first reported a position in MED in Q3 2014 and held it in 12 quarters. The position peaked at $5.17M in Q2 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

Secor Capital Advisors reported no remaining Medifast position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 4,706 Medifast shares in Q1 2019, an estimated $588K.
Secor Capital Advisors first reported a position in Medifast in Q3 2014 and held it in 12 quarters.
Secor Capital Advisors's Medifast position peaked at $5.17M in Q2 2018.
246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.